RDHL
Redhill Biopharma LtdNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$5.40M
P/E Ratio
0.00
EPS
$0.00
Beta
4.92
52W High
$3.31
52W Low
$0.71
50-Day MA
$0.89
200-Day MA
$1.25
Dividend Yield
—
Profit Margin
-150.00%
Forward P/E
1428.57
PEG Ratio
0.00
About Redhill Biopharma Ltd
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focused on gastrointestinal and infectious diseases. The company is headquartered in Tel Aviv, Israel.
Fundamentals
| Revenue (TTM) | 286,000 |
| Gross Profit (TTM) | 286,000 |
| EBITDA | $-7.50M |
| Operating Margin | -2765.00% |
| Return on Equity | -1709.00% |
| Return on Assets | -22.80% |
| Revenue/Share (TTM) | $6.18 |
| Book Value | $-2.45 |
| Price-to-Book | 1.32 |
| Price-to-Sales (TTM) | 18.88 |
| EV/Revenue | 9.55 |
| EV/EBITDA | 0.25 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 58.60% |
| Shares Outstanding | $5.19M |
| Float | $14.93B |
| % Insiders | 0.00% |
| % Institutions | 9.70% |
Historical Volatility
HV 10-Day
103.74%
HV 20-Day
80.13%
HV 30-Day
82.47%
HV 60-Day
66.38%
HV Rank
50.0%
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 5/5/2026